Feasibility, Acceptability, and Preliminary Effects of Lymfit

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

December 1, 2023

Conditions
Cancer SurvivorsLymphoma
Interventions
BEHAVIORAL

Lymfit Intervention

"Participants will be allocated a pre-registered Inspire II / Charge IV model Fitbit. The research team will reach out to the participant via videoconferencing and help them to: download the Fitbit smartphone application; log-in using the anonymous study identification information; and pair their Fitbit with their smartphone application.~A kinesiologist of the study will meet with the participants for a baseline fitness assessment. The kinesiologist will examine the baseline physical activity levels, fitness level and sedentary behaviours of the participants, to design a personalized exercise prescription. Within one week after the baseline fitness assessment, the kinesiologist will contact the participants to discuss the exercise prescription. Every two weeks there-after, the kinesiologist will follow up with the participants via videoconferencing to discuss their progress and to modify or advance their exercise prescriptions as needed, plus an acceptability assessment survey."

BEHAVIORAL

Wait-list control

Participants will be contacted by the study kinesiologist for a baseline fitness assessment 3 months after they consent, participants will be given a Fitbit, a personalized exercise prescription and receive bi-weekly follow-ups for 12 weeks.

Trial Locations (1)

H3A 2A7

Jewish General Hospital, Montreal

All Listed Sponsors
collaborator

Jewish General Hospital

OTHER

collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

lead

McGill University

OTHER